StockData
Oruka Therapeutics, Inc. logo

Oruka Therapeutics, Inc. (ORKA) stock

ORKANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$95.74−0.58 (-0.60%)

Close on Nov 18, 2026Market cap $6.34BP/E –Yield –

Oruka Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Oruka Therapeutics's price to book ratio was 5.9× on Nov 11, 2026, against 3.0× a year earlier. Over the last 5 years it ranged from 1.0× to 16.4×, with a median of 7.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.9×+2.9
2025Dec 31, 20253.0×+1.0
2024Dec 31, 20242.0×−5.8
2023Dec 29, 20237.7×−1.8
2022Dec 30, 20229.6×+3.0
2021Dec 31, 20216.6×−2.3
2020Dec 31, 20208.9×−3.6
2019Dec 31, 201912.4×+5.0
2018Dec 31, 20187.4×−5.9
2017Dec 29, 201713.3×+1.5
2016Dec 30, 201611.7×−0.6
2015Dec 31, 201512.3×−1.7
2014Dec 31, 201414.0×−0.5
2013Dec 31, 201314.5×−2.4
2012Dec 31, 201216.9×−5.1
2011Dec 30, 201122.0×–

More Oruka Therapeutics figures

See a number that looks wrong?